鍾邑林 醫師 Yih-Lin Chung

專長：

• 放射腫瘤
• 分子生物

學歷：

• 美國密西根大學遺傳碩士 (1995.07-1997.06)
• 陽明大學 醫學系 醫學士 (1984.10-1991.06 )

現職：

• 和信治癌中心醫院 放射腫瘤科 主治醫師專研醫師 1999.11~迄今

經歷：

• 美國密西根大學 分子醫學科 博士生及研究助理 1995.07~1997.08
• 台北榮總 癌病中心外科 住院醫師 1997.09~1999.10

專業學會：

• 放射線學會
• 放射腫瘤學會

著作：

1. Chung YL, and Tsai TY. Promyelocytic Leukemia Nuclear Bodies Link the DNA Damage Repair Pathway with Hepatitis B Virus Replication: Implications for Hepatitis B Virus Exacerbation during Chemotherapy and Radiotherapy. Mol Cancer Res 7(10):1672-1685, 2009.
2. Chung YL, Lee MY, and Pui MN. Epigenetic therapy using the histone deacetylase inhibitor for increasing therapeutic gain in oral cancer: prevention of radiation-induced oral mucositis and inhibition of chemical-induced oral carcinogenesis. Carcinogenesis 30(8):1387-1397, 2009.
3. Chung YL, Lee MY, Horng CF, Jian JJ, Cheng SH, Tsai SY, Hsieh CI, Yen LK, and Lin CY. Use of combined molecular biomarkers for prediction of clinical outcomes in locally advanced tonsillar cancers treated with chemoradiotherapy alone. Head Neck 31(1):9-20, 2009.
4. Chung YL, James Jer-Min Jian, Skye Hongiun Cheng, Stella Y.C. Tsai, Vincent P. Chuang, Thomas Soong, Yu-Mong Lin, Cheng-Fang Horng. Sublethal Irradiation Induces Vascular Endothelial Growth Factor and Promotes Growth of Hepatoma Cells: Implications for Radiotherapy of Hepatocellular Carcinoma. Clinical Cancer Research 12(9): 2706-2715, 2006.
5. Chung, YL, Jian JJ, Cheng SH, Hsieh CI, Tan TD, Chang HJ, Hung CF, Horng CF, Soong T, and Tsou MH. Extended-field radiotherapy and high-dose-rate brachytherapy with concurrent and adjuvant cisplatin-based chemotherapy for locally advanced cervical cancer: a phase I/II study. Gynecologic Oncology 97: 126-135, 2005.
6. Chung YL, Wang AJ, and Yao LF. Antitumor Histone Deacetylase Inhibitors Suppress Cutaneous Radiation Syndrome: Implications for Increasing Therapeutic Gain in Cancer Radiotherapy. Molecular Cancer Therapeutics 3(3): 317-325, 2004.
7. Chung YL, Lee MY, Wang AJ, and Yao LF. A Therapeutic Strategy Uses Histone Deacetylase Inhibitors to Modulate the Expression of Genes Involved in the Pathogenesis of Rheumatoid Arthritis. Molecular Therapy: The Official Journal of the American Society of Gene Therapy 8(5): 707-717, 2003.
8. Chung YL, Sheu ML, and Yen SH. Hepatitis C Virus NS5A as a Potential Viral Bcl-2 Homologue Interacts with Bax and Inhibits Apoptosis in Hepatocellular Carcinoma. International Journal of Cancer 107(1): 65-73, 2003.
9. Chung YL, Sheu ML, Yang SC, Lin CH, and Yen SH. Resistance to Tamoxifen-induced Apoptosis is Associated with Direct Interaction between Her2/neu and Cell Membrane Estrogen Receptor in Breast Cancer. International Journal of Cancer 97(3):306-312, 2002.
10. Chung YL, Lee Wu YH, Yen SH, and Chi KW. A Novel Approach for Nasopharyngeal Carcinoma Treatment Uses Phenylbutyrate as a Protein Kinase C Modulator: Implications for Radiosensitization and Epstein-Barr Virus-Targeted Therapy. Clinical Cancer Research 6(4):1452-1458, 2000.
11. Hu G, Chung YL, Glover T, Valentine V, Look AT, Fearon ER. Characterization of human homologs of the Drosophila seven in absentia (sina) gene. Genomics 46(1):103-111, 1997.